Search research articles
Contact Us
Filters
Showing results (91-100 of 94) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 94 results.
The Lancet. Oncology
|
June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 15, 2019
A multiparametric [<sup>18</sup>F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis
Doris Leithner, Joao V Horvat, Blanca Bernard-Davila, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Neuro-Oncology
|
December 23, 2015
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
Macarena I de la Fuente, Robert J Young, Jennifer Rubel, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 94) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 94 results.
The Lancet. Oncology
|
June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 15, 2019
A multiparametric [<sup>18</sup>F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis
Doris Leithner, Joao V Horvat, Blanca Bernard-Davila, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Neuro-Oncology
|
December 23, 2015
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
Macarena I de la Fuente, Robert J Young, Jennifer Rubel, et al.
Page
of 10